ClinicalTrials.gov
public full text
Public Domain
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
RATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors#1164487
- Phase I (PH I) Mad Refractory Solid Tumor Study#837880
- Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors#869470
- Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors#896682
- Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial#235402
Record · ID 873296
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive